Medicine & TechnologyA multi-center study in India about the black fungus affecting COVID-19 patients shows the reason behind the increased cases of the deadly fungi, which was observed even during the first wave of the pandemic.
Scientists are unsure whether COVID-19 is directly or indirectly attacking insulin-producing beta cells. However, numerous studies suggest that there is a link between diabetes and COVID-19.
A new study finding shows some COVID-19 survivors have recently developed diabetes. However, it remains unclear if such an occurrence could be considered a permanent adverse effect of the virus.
In a new study, scientists have presented that adding an investigational cancer drug to an extensively used treatment for diabetes enhances blood sugar control and weight loss in mice.
The Leona M. and Harry B. Helmsley Charitable Trust has awarded a $3.5M research grant to Clatit Health Services to evaluate its AI-driven study on the efficacy of diabetes care.
New study reveals risk factors of developing type 2 diabetes that are not genetic such as insomnia, sleep quality, and caffeine consumption. These specific risk factors can help create new preventive strategies of developing T2D as it is increasingly seen in obese children.
In a breakthrough discovery, metformin is found to be effective not only for diabetic patients, but for those with a genetic mutation that results in a specific form of ALS, or C9-ALS. Scientists are already in phase 2 of trials.